Novel therapies for multiple myeloma

A nano ultra-performance liquid chromatography-high resolution mass spectrometry approach for global metabolomic profiling and case study on drug-resistant multiple myeloma.

Analytical chemistry·2014

Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma.

Blood·2014

Daratumumab granted breakthrough drug status.

Expert opinion on investigational drugs·2014

IKKβ inhibitor in combination with bortezomib induces cytotoxicity in breast cancer cells.

International journal of oncology·2014

Heterogeneity of genomic evolution and mutational profiles in multiple myeloma.

Nature communications·2014

A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma.

Blood·2014

Immune features of graft-derived mucosal-associated invariant T cells predict gastrointestinal graft-versus-host disease.

British journal of haematology·2026

Venetoclax-enhanced reduced-intensity conditioning in older patients aged ≥55 years with high-risk myeloid malignancies undergoing allogeneic peripheral blood stem cell transplantation: A phase II study.

British journal of haematology·2026

Socioeconomic inequality in treatment of acute myeloid leukaemia (AML) in England, 2015-2022: A population-based study.

British journal of haematology·2026

Real-world outcomes of BrECADD therapy in advanced-stage classical Hodgkin lymphoma: A multicentre retrospective study.

British journal of haematology·2026

Red lines and green lights: Gene therapy for inherited erythroid disorders beyond the haemoglobinopathies.

British journal of haematology·2026

Targeting nuclear export and Janus Kinase/Signal Transducer and Activator of Transcription (JAK/STAT) signalling in myelofibrosis: A novel combinatorial strategy that impacts intrinsic and microenvironment-related pathways.

British journal of haematology·2026

Development of a Novel, Eco-Friendly Mechanical Cell Lysis Process Using Hollow Fiber Filter for AAV Manufacturing.

Biotechnology and bioengineering·2026

Programmed repair of disease-causing UGA premature termination codons in mammalian brain.

Nucleic acids research·2026

Case Report: Novel homozygous pathogenic variant of the SPG20 gene causes the Troyer syndrome in China.

Frontiers in genetics·2026

Molecular profiling and functional analyses of umbilical cord mesenchymal stem cell-derived extracellular vesicles for dry eye diseases.

Extracellular vesicles and circulating nucleic acids·2026

Immunotherapy for tuberculosis: current landscape, mechanistic insights, and translational perspectives.

Frontiers in immunology·2026

Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe Psoriasis After Failure of Ustekinumab: A Multicenter Retrospective Study.

The Journal of clinical and aesthetic dermatology·2026

Related Experiment Videos

Novel therapies for multiple myeloma

Related Concept Videos

A nano ultra-performance liquid chromatography-high resolution mass spectrometry approach for global metabolomic profiling and case study on drug-resistant multiple myeloma.

Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma.

Daratumumab granted breakthrough drug status.

IKKβ inhibitor in combination with bortezomib induces cytotoxicity in breast cancer cells.

Heterogeneity of genomic evolution and mutational profiles in multiple myeloma.

A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma.

Immune features of graft-derived mucosal-associated invariant T cells predict gastrointestinal graft-versus-host disease.

Venetoclax-enhanced reduced-intensity conditioning in older patients aged ≥55 years with high-risk myeloid malignancies undergoing allogeneic peripheral blood stem cell transplantation: A phase II study.

Socioeconomic inequality in treatment of acute myeloid leukaemia (AML) in England, 2015-2022: A population-based study.

Real-world outcomes of BrECADD therapy in advanced-stage classical Hodgkin lymphoma: A multicentre retrospective study.

Red lines and green lights: Gene therapy for inherited erythroid disorders beyond the haemoglobinopathies.

Targeting nuclear export and Janus Kinase/Signal Transducer and Activator of Transcription (JAK/STAT) signalling in myelofibrosis: A novel combinatorial strategy that impacts intrinsic and microenvironment-related pathways.

Development of a Novel, Eco-Friendly Mechanical Cell Lysis Process Using Hollow Fiber Filter for AAV Manufacturing.

Programmed repair of disease-causing UGA premature termination codons in mammalian brain.

Case Report: Novel homozygous pathogenic variant of the SPG20 gene causes the Troyer syndrome in China.

Molecular profiling and functional analyses of umbilical cord mesenchymal stem cell-derived extracellular vesicles for dry eye diseases.

Immunotherapy for tuberculosis: current landscape, mechanistic insights, and translational perspectives.

Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe Psoriasis After Failure of Ustekinumab: A Multicenter Retrospective Study.

Related Experiment Videos

Novel therapies for multiple myeloma

Related Concept Videos

Related Articles